Scientific Programme

SHC 2019 Programme

The preliminary conference programme is subject to change

 

FRIDAY 7 JUNE 2019

Time

Programme

08:30 – 09:45

08:30 – 8:45

Welcome remarks by the Conference Chairman and SHC partners

CHB Therapy

08:45 - 09:00

Optimisation of current CHB therapy

09:00 - 09:15

Practical issues in clinical management of CHB

09:15 - 09:30

Future Therapies for HBV leading to functional cure

09:30 - 09:45

Round table discussion

09:45 –  10:00

Tea Break

10:00 –  10:45

CHB Treatment Special Groups

Chairs:

10:00 - 10:15

The good and bad of Hepatitis B flares

10:15 - 10:30

CHB and cirrhosis: progression or regression?

10:30 - 10:45

Round table discussion

10:45 - 11:45

Controversial Issues in CHB

10:45 - 11:15

Debate: Should we treat CHB to prevent HCC?

·         To Treat:

·         Not to treat:

11:15 - 11:45

Round table discussion

11:45 - 13:30

HBV-HCC Lunch Case Discussion

13:30 - 15:15

HCC Symposium Part 1

13:30 – 13:45

Molecular and immune pathways in HCC pathogenesis

13:45 – 14:00

New diagnostic and surveillance tools for early detection of HCC

14:00 – 14:45

Debate: Management of small HCC

·         Surgery:

·         Loco-regional therapy:

·         Liver Transplant:

14:45 – 15:15

Forum for management of small HCC: Therapeutic options and patient selection

15:15 - 15:30

Tea Break

15:30 - 16:30

HCC Symposium Part 2

15:45 – 16:00

Combination therapy or sequential therapy of HCC

16:00 – 16:15

Debate: systemic therapy for HCC should be managed by Oncologists

16:15 – 16:30

Debate: systemic therapy for HCC should be managed by Hepatologists

16:30 - 18:00

The Future of Systemic Therapies Forum

     

SATURDAY 8 JUNE 2019

Time

Programme

 09:00 – 10:45

HCV Management

09:00 – 09:30

Debate: Treatment for HCV should be personalised

·         For :

·         Against :

09:30 – 09:45

DAA induced HCC - fact or fiction?

09:45 – 10:00

DAA Treatment failures and resistance:

10:00 - 10:15

Difficult to treat patients: CKD

10:15 - 10:45

Forum for HCV eradication: Country updates

10:45 – 11:00

Tea Break

11:00 – 12:15

Hot Topics in Hepatology Symposium

11:00 – 11:15

Non-invasive / invasive diagnosis of liver  fibrosis: serological, mechanical or both?

11:15 – 11:30

New Treatments for Autoimmune and Cholesteric Liver Disease

11:30 – 11:45

Update on metal disease affecting the liver: An Asian perspective

11:45 – 12:00

Alcoholic Liver Disease: a problem in Asia?

12:00 – 12:15

Round table discussion

12:15– 14:00

HCV-NASH Lunch Case Discussion 

14:00 – 15:30

Non-Alcoholic Fatty Liver Disease Symposium

14:00 – 14:15

Pathophysiology and risk factors for NAFLD

14:15 – 14:30

NAFLD and the microbiome

14:30 – 14:45

NAFLD & NASH: best evidence for dietary control

14:45 – 15:00

Optimising Current management of NASH

15:00 – 15:15

New Therapeuties for NASH: can we pick the winners?

15:15 - 15:30

Discussion Forum

15:30 - 15:45

Tea Break

15:45 - 17:30

Advanced Liver Disease Symposium

15:45 - 16:00

Update on management of portal hypertension

16:00 - 16:15

Sarcopenia in cirrhosis

16:15 - 16:30

Acute on Chronic Liver Failure

16:30 - 16:45

Diuretic resistant ascites

16:45 - 17:00

Current trends in Liver Transplantation in Asia

17:00 - 17:30

Round table discussion

17:30

Conclusion